Why cholesterol doesn't matter

William Davis , MD

22,534 views • 3 days ago Save 8 min 4 min read

Video Summary

For decades, the medical community has focused on cholesterol as the primary driver of heart disease, a notion the speaker calls a "semi-fiction." This outdated approach, perpetuated by the lucrative pharmaceutical industry, has overshadowed advancements in understanding atherosclerosis. The speaker argues that cholesterol measurements are a crude, indirect proxy for the real culprits: lipoproteins, particularly small, dense LDL particles.

These particles, along with VLDL and high triglyceride levels, are directly linked to a cascade of metabolic issues including insulin resistance, inflammation, and fatty liver disease. By shifting focus from total cholesterol to quantifying lipoprotein particle numbers, especially small dense LDL, a more accurate picture of heart disease risk emerges. The speaker proposes that targeting and reducing these specific lipoproteins, measurable through advanced techniques like NMR, offers a more effective strategy for preventing heart disease than relying on traditional cholesterol metrics.

Short Highlights

Cholesterol is a marker, not the cause of heart disease.
Lipoproteins, especially small dense LDL, are the true drivers of atherosclerosis.
Advanced measurement techniques like NMR provide a more accurate risk assessment.

Key Details

The Cholesterol Myth [00:06]

The prevailing focus on cholesterol as the cause of heart disease for the past 60-70 years is a "semi-fiction" that has persisted due to its profitability for the pharmaceutical industry.
While technology in other areas has advanced, the understanding and treatment of heart disease remain stuck in outdated methods.

"It's kind of like going back to the 1960s and watching a black and white bulky TV that's run on vacuum tubes."

The Evolution of Understanding Lipoproteins [01:47]

Hundreds of studies have advanced the understanding of coronary atherosclerosis, but this knowledge isn't widely disseminated.
In the 1950s and 1960s, research at the NIH identified lipoproteins (fat-carrying protein particles) as the components that contact artery walls and initiate atherosclerosis.
Measuring the exact number of these particles was difficult with the technology of the time.

"They said, 'If we can't really measure the number of particles very easily, what if we just take one of the ingredients in those particles?'"

The Crude Measurement of Cholesterol [03:43]

Scientists chose to measure cholesterol, a common ingredient across different lipoprotein layers, because it was easier to quantify than particle counts.
This method was crude because the content of cholesterol varies significantly even among particles within the same layer (e.g., LDL).
Cholesterol, intended as a marker, became mistakenly identified as the cause of coronary disease.

"Cholesterol was therefore a crude indirect marker, but it became misconstrued as the cause also of coronary disease."

The Real Culprits: VLDL and Small Dense LDL [05:44]

The speaker will focus on actual lipoproteins, particularly VLDL (very low-density lipoprotein) and small, dense LDL particles.
VLDL is rich in triglycerides and is the most low-density fraction.
Small dense LDL particles are a key component within the LDL layer that contribute to atherosclerosis.

"And the most important lipoprotein is two. That VLDL, the very low density lipoprotein fraction."

The Power of Particle Count vs. Cholesterol Level [06:20]

A conventional LDL cholesterol level of 180 mg/dL provides limited information.
In contrast, a small dense LDL particle count of 1,800 nanomoles per liter reveals a constellation of abnormal metabolic phenomena.
This high particle count indicates issues like de novo lipogenesis (excessive fat production in the liver from carbohydrates), high blood glucose and insulin, inflammation, and insulin resistance.

"We now know a whole constellation of abnormal phenomena. That's how coronary disease, coronary atherosclerosis is caused."

The Cascade of Metabolic Dysfunction [07:23]

High carbohydrate intake leads to de novo lipogenesis in the liver, producing triglycerides.
These triglycerides are packaged into VLDL particles, which can directly contribute to arterial plaque formation.
VLDL interacts with LDL, making it triglyceride-rich and converting it into small, dense LDL particles.

"So, carbohydrates are taken in through diet. Liver converts them to triglycerides, de novo lipogenesis."

The Dominance of Small Dense LDL [10:08]

Focusing on small dense LDL particles is presented as the key to simplifying the understanding and management of heart disease risk.
By measuring and correcting levels of small dense LDL, other related metabolic issues tend to resolve automatically.

"But, the truth of it is, if you just focus on the first thing, small dense LDL particles, and we learn how to measure that and correct it, everything else will follow."

Advanced Measurement: NMR [10:56]

The most common and accurate method for measuring lipoproteins is Nuclear Magnetic Resonance (NMR).
NMR, using a device similar to an MRI, can precisely deconstruct the composition, number, and size of lipoproteins.
This method is inexpensive, accessible, and should be covered by insurance, despite potential resistance from some healthcare providers.

"The NMR method has become kind of the gold standard. And it's inexpensive and accessible, and you can get it just about anywhere in the country, paid for by insurance."